Загрузка...
The Bruton tyrosine kinase inhibitor ibrutinib improves anti-MAG antibody polyneuropathy
OBJECTIVE: To assess whether neuropathy with anti-myelin-associated glycoprotein (MAG) antibody may improve after treatment with ibrutinib, an oral inhibitor of Bruton tyrosine kinase, we prospectively treated with ibrutinib a cohort of 3 patients with anti-MAG neuropathy and Waldenström macroglobul...
Сохранить в:
| Опубликовано в: : | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Lippincott Williams & Wilkins
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7176252/ https://ncbi.nlm.nih.gov/pubmed/32284437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000720 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|